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Abstract

the needs of the patient, subjective and/or objective measurement of the key variables (such as pain, agitation, and level of
consciousness), and titration of therapy to achieve specific
targets [1-4]. It is important to recognize that patient needs
can differ depending upon clinical circumstances, and that for
any given patient therapeutic targets are likely to change over
time. Thus, achieving patient comfort and ensuring patient
safety, including avoidance of excessive or prolonged
sedation, relies on accurately measuring pain, agitation,
sedation, and other related variables utilizing validated tools
that are easy to use, precise, accurate, and sufficiently robust
to include a wide range of behaviors. The consequences of
inadequate control of pain or agitation are considerable, but
excessive or prolonged sedation is also problematic, leading
to increased risk for complications of critical care. In addition
to promoting a consistent, goal-directed approach to
management, the systematic use of these tools enhances
communication among care providers.

Management of analgesia and sedation in the intensive care unit
requires evaluation and monitoring of key parameters in order to
detect and quantify pain and agitation, and to quantify sedation.
The routine use of subjective scales for pain, agitation, and
sedation promotes more effective management, including patientfocused titration of medications to specific end-points. The need
for frequent measurement reflects the dynamic nature of pain,
agitation, and sedation, which change constantly in critically ill
patients. Further, close monitoring promotes repeated evaluation of
response to therapy, thus helping to avoid over-sedation and to
eliminate pain and agitation. Pain assessment tools include selfreport (often using a numeric pain scale) for communicative
patients and pain scales that incorporate observed behaviors and
physiologic measures for noncommunicative patients. Some of
these tools have undergone validity testing but more work is
needed. Sedation-agitation scales can be used to identify and
quantify agitation, and to grade the depth of sedation. Some scales
incorporate a step-wise assessment of response to increasingly
noxious stimuli and a brief assessment of cognition to define levels
of consciousness; these tools can often be quickly performed and
easily recalled. Many of the sedation-agitation scales have been
extensively tested for inter-rater reliability and validated against a
variety of parameters. Objective measurement of indicators of
consciousness and brain function, such as with processed electroencephalography signals, holds considerable promise, but has not
achieved widespread implementation. Further clarification of the
roles of these tools, particularly within the context of patient safety,
is needed, as is further technology development to eliminate
artifacts and investigation to demonstrate added value.

Here we review the available subjective instruments for
evaluating pain, sedation, and agitation in the critically ill adult
patient, as well as the results of validation and clinical
application studies. Additionally, although objective tools,
such as cerebral function monitoring, have not achieved
widespread application in the ICU setting, the principles and
potential roles of objective measurements related to
analgesia and sedation are discussed.

Introduction

Assessment of pain and analgesia

Effective management of analgesia and sedation in the
intensive care unit (ICU) setting requires an assessment of

Optimal pain assessment in adult critical care settings is
essential because it has been reported that 35% to 55% of

ATICE = Adaptation to Intensive Care Environment; BPS = Behavior Pain Scale; BIS = Bispectral Index; CPOT = Critical Care Pain Observation
Tool; CSI = Cerebral State Index; EEG = electroencephalography; EMG = electromyogram; FLACC = Face, Legs, Activity, Cry, Consolability
Observational Tool; ICU = intensive care unit; MSAT = Minnesota Sedation Assessment Tool; NPS = Numeric Pain Scale; PSI = Patient State
Index; RASS = Richmond Agitation-Sedation Scale; RSS = Ramsay Sedation Scale; SAS = Sedation Agitation Scale; SCCM = Society of Critical
Care Medicine; VICS = Vancouver Interactive and Calmness Scale.

Page 1 of 13
(page number not for citation purposes)

Critical Care

Vol 12 Suppl 3

Sessler et al.

nurses underrate the patient’s pain [5-7], and in one study [8]
64% of patients did not receive any medications before or
during painful procedures. In the SUPPORT (Study to
Understand Prognoses and Preferences for Outcomes and
Risks of Treatment) study [9], nearly 50% of patients
reported pain, 15% reported moderately or extremely severe
pain that occurred at least half of the time, and nearly 15%
were dissatisfied with their pain control. Inaccurate pain
assessment and the resulting inadequate treatment of pain in
critically ill adults can have significant physiologic consequences. For example, pain increases myocardial workload,
which can lead to myocardial ischemia, or to splinting,
atelectasis, and a cascade of events that in turn can lead to
pneumonia [10].
Patient self-report is the best indicator of pain, specifically
using the numeric pain rating scale ranging from 0 to 10.
However, many critically ill patients are unable to communicate effectively because of cognitive impairment, sedation,
paralysis, or mechanical ventilation. Identification of the
optimal pain scale in such patients is ongoing, and no single
tool is universally accepted for use in the noncommunicative
patient [1,11]. When a patient cannot express themself,
observable indicators - both physiologic and behavioral - have
been treated as pain-related behaviors to evaluate pain in this
population [12,13]. National pain guidelines support evaluation of both physiologic and behavioral response to pain in
patients who are unable to communicate [14]. Additionally, in
the Clinical Practice Guidelines for Sustained Use of
Sedatives and Analgesics in the Critically Ill Adult published
by the Society of Critical Care Medicine (SCCM) [1], regular
assessment and documentation of pain and response to
therapy is recommended (grade C).
There is a direct relationship between the ability to assess
and document a patient’s pain and the ability to manage pain
[15,16]. However, Gelinas and coworkers [17] found that of
183 documented pain episodes in intubated patients, use of
a pain scale was mentioned in only 1.6% of cases. Although
assessment of patient pain behaviors was common (73% of
episodes), these assessments were observed and
documented without the use of a valid and reliable pain tool.
In a recent description of 1,360 mechanically ventilated,
critically ill patients, Payen and coworkers [18] found that
pain was not assessed in 53% of patients who were
receiving analgesia, and when pain was assessed specific
pain tools were used only 28% of the time. Inadequate pain
control is largely due to inconsistent use of standardized
tools. Therefore, use of a valid and reliable tool to assist
health care providers in the management of pain in the
critically ill, sedated patient is paramount [1,19].

Pain assessment: communicative patients
The Numeric Pain Scale (NPS) employs a verbal rating of
pain on a scale from 0 to 10, with 10 being the worst pain
ever experienced, and is broadly used in a variety of clinical
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settings. It has been successfully used to evaluate pain in
older adults [20], change in pain intensity [21], assessment
of pain reduction [22], and evaluation of pain in geriatric
patients [23], as well as in communicative critically ill patients
to evaluate procedural pain [24]. Self-reported pain is
considered to be the standard, and the NPS is recommended
by SCCM (grade B recommendation). However, data to
support its efficacy compared with other pain tools used in
the noncommunicative patient are limited.

Pain assessment: noncommunicative patients
A variety of tools focusing on behavioral and physiologic
indicators of pain are being used to evaluate pain intensity in
noncommunicative patients, but evidence of their validity and
reliability in critically ill patients is limited. Two pain scales
presently used in adult critical care settings (COMFORT
scale and the Face, Legs, Activity, Cry, Consolability
Observational Tool [FLACC] scale) were originally developed
and validated in the pediatric population. Although
noncommunicative critically ill adults are similar to newborns,
infants, and preverbal toddlers in being unable to report and
describe pain, some behavioral components of these tools for
children are not applicable to adults. Furthermore, validation
of these tools in adults is limited.
Pediatric pain tools adapted for use in adults
The COMFORT scale contains behavioral and physiologic
factors (eight items, each scored from 1 to 5) to evaluate pain
and was originally designed to assess distress in pediatric
ICU patients [25]. The scale measures alertness, calmness,
facial tension, physical movement, muscle tone, ventilator
respiratory response, blood pressure and heart rate, and it
exhibits good inter-rater reliability [26].

The FLACC was developed to provide a simple and consistent method for nurses to identify, document, and evaluate
pain in children [27,28]. The FLACC scale assesses pain by
using behavioral indicators and assessment of body movements (face, legs, activity), verbal responses (cry), and
consolability. It has been validated for assessing pain in
children with cognitive impairment, in young children [29] and
in children with postoperative pain [27], and in comparison
with children’s self report of pain [30]. However, there are
few data to support its use in adult critically ill patients.
Specific components such as cry and consolability are not
appropriate for the critically ill, intubated adult.
Adult-specific pain tools
The Behavior Pain Scale (BPS) [15] is based on a sum score
of three items: facial expression, movements of upper limbs,
and compliance with mechanical ventilation. Based upon the
assumption that a relationship exists between each score and
pain intensity, each pain indicator is scored from 1 (no
response) to 4 (full response), with a maximum score of 12.
Initial validity and reliability was established using 269
assessments in 30 sedated mechanically ventilated patients
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during painful procedures (endotracheal suctioning and
mobilization) as well as nonpainful procedures (compression
stocking application, central venous catheter dressing
change). Nociceptive stimulation resulted in higher BPS
values than did non-nociceptive stimuli (4.9 versus 3.5;
P < 0.01), whereas the groups had comparable scores prior
to stimulation. Excellent inter-rater reliability was also found
during multiple testing (r2 = 0.50 to 0.71). Young and coworkers [30] conducted additional validity and reliability
testing of the BPS in critically ill patients during routine
painful and nonpainful procedures. A significant (P < 0.003)
increase in BPS scores was found after painful procedures,
and no significant increase was found after the nonpainful
procedure. The odds of an increase in BPS between preprocedure and post-procedure assessments were more than
25 times higher for repositioning (painful) compared with eye
care (nonpainful; P < 0.0001), after controlling for analgesics
and sedatives. A limitation of BPS is that responsiveness
(increase in score in response to noxious stimuli) decreases
substantially with deepening levels of sedation [15]. In
addition, because compliance with mechanical ventilation
may be considered to be a separate domain from the other
behaviors, some intensivists only score facial expression and
movements of upper limbs in order to assess the individual
pain state.
Chanques and coworkers [31] evaluated pain in 230 ICU
patients using the combination of BPS (for noncommunicative patients) and NPS (for communicative patients). The
periods considered were a 21-week control phase with usual
care as regards pain evaluation, and a subsequent 29-week
intervention phase, during which nurses assessed pain levels
using the two tools and notified physicians of high pain levels.
The incidence of pain as well as the rate of severe pain
events decreased significantly during the intervention phase.
A significant decrease in the duration of mechanical
ventilation was also noted [18].
The Adult Nonverbal Pain Scale is a modification of the
FLACC scale and was developed for use in adult, noncommunicative patients. It evaluates five parameters: face,
activity, guarding, physiologic I (vital signs), and physiologic II
(skin and pupils). It has been pilot tested in a burn-trauma unit
during all three patient care shifts in 200 paired assessments
with the FLACC scale [32]. It exhibited good correlation with
the FLACC scale (r = 0.86, P < 0.001). Although it shows
promise as a tool for use in the nonverbal adult population, it
has not been evaluated against any other measures of pain in
the adult population.
A recently developed behavior pain tool, the Critical Care
Pain Observation Tool (CPOT), has four components: facial
expression, body movements, muscle tension, and compliance with the ventilator for intubated patients or vocalization for extubated patients. Each of these behaviors is
assigned a rating of 0 to 2. The CPOT was adapted from

three different pain assessment tools [15,25,33] and three
different descriptive/qualitative studies [13,17,34]. Gelinas
and coworkers [34] conducted a validation study in 105
cardiac surgery patients, using periods of rest, nociception,
and 20 minutes after the nociceptive procedure (positioning)
during three separate testing periods while patients were
conscious and unconscious. The tool exhibited criterion
validity because significant associations were found between
the patients’ self-reports of pain and CPOT, whereas
discriminant validity was supported by higher scores during
the nociceptive procedure compared with the score at rest.
Inter-rater reliability was also good. Of note, changes in
scores with nociceptive stimulation were similar whether the
patient was conscious or unconscious.
Current practice for adult ICU patients commonly includes a
combination of NPS or similar self-reported pain quantification tool, plus an instrument designed to identify pain using
behavior and physiologic parameters in the noncommunicative patient. This sequential approach is supported in
the form of grade B recommendations from the SCCM [1].
More work is needed to provide convincing evidence of the
validity of these tools as well as to address limitations in
application, such as how to assess for pain in the presence of
heavy sedation. Although new scales and additional validation
studies are frequently reported in this evolving field, we
support use of either the BPS or CPOT for noncommunicative scales (Tables 1 and 2). Combining pain testing with a
standardized approach to management can lead to better
pain control without prolonging the duration of mechanical
ventilation [31].

Sedation and agitation scales
The Ramsay Sedation Scale (RSS) was introduced more
than 30 years ago as a subjective tool with which to evaluate
precisely the level of consciousness during titration of
sedative medications in the ICU [35]. Since then, numerous
subjective instruments have been developed, validated, and
applied in clinical and research settings to monitor level of
consciousness or arousal, as well as to evaluate cognition,
agitation, patient-ventilator synchrony, and other parameters.
These include the Sedation Agitation Scale (SAS) [36], the
Motor Activity Assessment Scale [37], the Vancouver
Interactive and Calmness Scale (VICS) [38], the Richmond
Agitation-Sedation Scale (RASS) [39], the Adaptation to
Intensive Care Environment (ATICE) instrument [40], and the
Minnesota Sedation Assessment Tool (MSAT) [41] (Table 3).
In order for such a tool to be effective in the busy ICU setting,
the users must be confident that it accurately measures what
is intended, that it is reliable, and that it is easy to apply
repeatedly by multiple care providers [42]. Desirable features
of a good sedation scale have been enumerated and include
the following [43]: rigorous multidisciplinary development;
ease of administration, recall, and interpretation; well defined
discrete criteria for each level; sufficient sedation levels for
effective drug titration; assessment of agitation; and
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Table 1
Behavioral Pain Scale
Item

Description

Facial expression

Relaxed

1

Partially tightened (for example, brow lowering)

2

Fully tightened (for example, eyelid closing)

3

Grimacing

4

Upper limbs

Compliance with ventilation

Score

No movement

1

Partially bent

2

Fully bent with finger flexion

3

Permanently retracted

4

Tolerating movement

1

Coughing but tolerating ventilation for most of the time

2

Fighting ventilator

3

Unable to control ventilation

4

Scores from each of the three domains are summed, with a total score of 3 to 12 [15].
Table 2
Critical Care Pain Observational Tool
Indicator

Description

Facial expression

No muscular tension observed

Relaxed, neutral: 0

Presence of frowning, brow lowering, orbit tightening, and levator contraction

Tense: 1

Body movements

Muscle tension

Compliance with the
ventilator

Score

All of the above facial movements plus eyelid tightly closed

Grimacing: 2

Does not move at all (does not necessarily mean absence of pain)

Absence of movements: 0

Slow, cautious movements, touching or rubbing the pain site, seeking attention
through movements

Protection: 1

Pulling tube, attempting to sit up, moving limbs/thrashing, not following
commands, striking at staff, trying to climb out of bed

Restlessness: 2

No resistance to passive movements

Relaxed: 0

Resistance to passive movements

Tense, rigid: 1

Strong resistance to passive movements, inability to complete them

Very tense or rigid: 2

Alarms not activated, easy ventilation

Tolerating ventilator or
movement: 0

Alarms stop spontaneously

Coughing but tolerating : 1

Asynchrony: blocking ventilation, alarms frequently activated

Fighting ventilator: 2

Talking in normal tone or no sound

Talking in normal tone or
no sound: 0

Sighing, moaning

Sighing, moaning: 1

Crying out, sobbing

Crying out, sobbing: 2

OR
Vocalization
(extubated patients)

Scores for each of the four domains are summed, with a total score of 0 to 8 [34].

demonstration of inter-rater reliability and evidence for validity
in relevant patient populations.
Recommendations and use of sedation scales in
intensive care units
The routine use of a sedation scale in ICU patients who are
receiving sedative medications is endorsed in SCCM’s
Clinical Practice Guidelines for Sustained Use of Sedatives
and Analgesics in the Critically Ill Adult [1] and is supported
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by other expert reviews [2-4]. The SCCM guidelines
specifically recommend that a sedation goal or end-point
should be established and regularly redefined for each
patient, and that regular assessment and response to therapy
should be systematically documented (grade C recommendation) [1]. The use of a validated sedation assessment scale
was also specifically recommended (grade B recommendation). Additionally, the treatment algorithm depicted in the
guidelines indicate that clinicians should use a sedation scale

Six levels: four levels of sedation defined by responses
to stimuli (levels 3 to 6), a level of ‘cooperative, oriented,
and tranquil’ (level 2), and a level for ‘anxious,
agitated, or restless’ (level 1)

Seven levels: three levels of agitation (levels 5 to 7),
a ‘calm and cooperative’ level (level 4), and three
levels of sedation (levels 1 to 3). All levels are
defined by multiple (3 or 4) criteria

Seven levels: three levels of agitation (levels 4 to 6),
a ‘calm and cooperative’ level (level 3), and three
levels of sedation (levels 0 to 2). All levels are
defined by multiple (3 to 4) criteria

Contains two domains (‘interaction’ and ‘calmness’).
Each domain has five questions, and each question
has six responses from ‘strongly agree’ to ‘strongly
disagree’. Patient stimulation required for some
questions. Scores are summed (maximum 30/domain),
with higher scores for calm and interactive

Ten level scale: four levels of agitation (levels +1 to +4),
a level for ‘calm and alert’ (level 0), and five levels
of sedation (-1 to -5) defined by response to verbal
then physical stimulation, plus consideration of
cognition and sustainability

Sedation Agitation Scale
(SAS; 1994) [85]

Motor Activity
Assessment Scale
(MAAS; 1999) [37]

Vancouver Interactive
and Calmness Scale
(2000) [38]

Richmond AgitationSedation Scale
(RASS; 2002) [39]

Scale design

Ramsay Sedation
Scale (RSS; 1974) [35]

Scale
(year developed) [ref.]

Sedation and sedation-agitation scales

Table 3

r = 0.956. K = 0.73 for five raters
(2 MD, 2 RN, and 1 PharmD) [39]
r = 0.964, K = 0.80 nurse educator
versus 27 RNs [39]
K = 0.91 RN [58]
K = 0.89 RN versus rater [90]
K = 0.77 RN versus rater [90]

r = 0.89 for calmness score
r = 0.90 for interactive score

Continued overleaf

Versus VAS r = 0.93 (95% CI 0.84 to 0.98) [39]
Versus GCS (r = 0.79) [39]
Versus RSS (r = -0.78) [39]
Versus SAS (r = 0.78) [39]
Differences in consciousness (P < 0.001) [58]
Fluctuation in consciousness (P < 0.001) [58]
Versus attention screening (r = 0.78) [58]
Versus GCS (r = 0.91) [58]
Versus quantity of Rx (r = -0.31) [58]
Versus BIS (r = 0.63) [58]
Face validity 92% agreed [58]
Versus BIS XP (r = 0.81) [68]
Versus BIS v2.1.1 (r = 0.30) [68]
Versus BIS XP (r2 = 0.36) [69]
Versus BIS 3.4 (r2 = 0.20) [69]
Versus actigraphy (r = 0.58) [62]
Versus COMFORT scale (r = 0.75) [62]

Calmness score versus need for intervention r = -0.83 [38]
Minimal clinical important difference, calmness = -2.2 [38]
Minimal clinical important difference, interaction = 2.5 [38]
Guyatt’s responsiveness statistic, calmness = -1.4 [38]
Guyatt’s responsiveness statistic, interaction = 2.3 [38]

Versus VAS (P = 0.001) [37]
Versus BP (P = 0.001) [37]
Versus HR (P = 0.001) [37]
Versus agitation-related sequelae (P = 0.001) [37]

Versus RSS (r2 = 0.83) [36]
Versus VAS sedation r = -0.77) [59]
Versus Harris (r2 = 0.86) [36]
Versus BIS (r2 = 0.21) [65]
Versus VAS, researcher (r = 0.9) [61]
Versus VAS, nurses (r = 0.43) [61]
Versus BIS 3.2 (r = 0.6) [61]
Versus BIS (r = 0.36) [66]
Versus BIS, exclude motor excess (r = 0.50) [66]
Versus BIS (r2 = 0.48 before, 0.44 after stimulation) [67]
Versus digital imaging [70]
Versus BIS XP (r = 0.725) [68]
Versus BIS v2.1.1 (r = 0.376) [68]

r2 = 0.83, K = 0.92 [36]
K = 0.93 [59]
K = 0.85 investigators [59]
K = 0.87 RNs [59]

K = 0.83 (95% CI 0.72 to 0.94) [37]
r = 0.81, 3RN, 1MD, 1PharmD [60]

Versus RASS (r = -0.78) [39]
Versus BIS (P < 0.01) [63]
Versus BIS v2.10 (r = -0.27) [64]
Versus BIS XP v3.10 (r = -0.40) [64]

Validity

K = 0.94, RNs [58]

Reliability
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r = 0.86 to 0.99 RN versus MD [40]
r = 0.82 to 0.99 RN versus research
RN [40]
r = 0.91 to 0.99 research RN versus
MD [40]

Arousal scale K = 0.85 [41]
Motor scale K = 0.72 [41]

Five tests in two domains: consciousness and
tolerance domains. Tests included in the
consciousness domain: awakeness scale (five levels
from 0 = eyes closed, no mimic, to 5 = eyes open
spontaneously, based on verbal then physical
stimulation) and comprehension scale (score based
on summing 1 point each for positive response to
five commands). Tests included in the tolerance
domain: calmness scale (four levels from 3 = calm to
0 = life-threatening agitation), ventilator synchrony
scale (score based on summing 1 point for each of
four observed events) and face relaxation scale (four
levels from 3 = relaxed face to 0 = permanent grimacing)

Two domains: arousal and motor activity. Arousal is a
six-level scale (1 = deeply sedated to 6 = alert) based
on eye opening or movement responses to verbal then
physical stimulation. Motor scale has four levels
(1 = no movement to 4 = central muscle group
movement)

Adaptation to Intensive
Care Environment
(ATICE; 2003) [40]

Minnesota Sedation
Assessment Tool
(MSAT; 2004) [41]
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to assess for agitation/anxiety [1]. Historically, the use of a
sedation scale has been disappointingly low, with sedation
assessment performed in fewer than one-half of ICU patients,
ICUs, and days of observation in multiple studies from
throughout the world [44-50].
BIS, Bispectral Index; CI, confidence interval; GCS, Glasgow Coma Scale; K, κ statistic; MD, physician; PharmD, pharmacist; RN, registered nurses; VAS, visual-analog scale.

Reliability

Arousal scale: r = 0.68 versus VICS [41]
Motor scale: r = -0.41 versus calmness subscale of VICS
[41]
Convergent validity present for arousal and motor [41]
Predictive validity present for arousal only [41]

Sessler et al.

Internal consistency = 0.67 to 0.87 [40]
Versus RSS (r = 0.40 to 0.86) [40]
Versus SAS (r = 0.37 to 0.75) [40]
Versus GCS (r = 0.78 to 0.95) [40]
Versus COMFORT scale (r = 0.38 to 0.83) [40]
Versus VAS (r = 0.41 to 0.92) [40]
Versus sedative plus analgesics (r = 0.45 to 0.72) [40]

Vol 12 Suppl 3

Scale design
Scale
(year developed) [ref.]

Table 3 (continued)

Validity

Critical Care

Although all of the aforementioned studies were performed
before publication of the SCCM guidelines in 2002, a
recently reported prospective surveillance study conducted in
44 ICUs during 2004 revealed that sedation assessment is
still not performed in many patients who are receiving
sedative drugs [18]. For example, on the second ICU day,
72% of patients were receiving sedative medications but only
43% received sedation assessment. The missed opportunity
to titrate medications effectively by using a sedation scale is
apparent, because 57% of assessed patients were under
deep sedation [18].
Structure of sedation scales
Each sedation scale is constructed somewhat differently
(Table 3), although there are several common themes regarding domains to be evaluated and the structure of the
instrument. The key domain of most scales is consciousness,
typically ranging from alert to comatose, with a subdomain of
arousal or awakeness, often in response to stimuli of increasing intensity (as with RSS, RASS, ATICE, and MSAT). In
addition, higher states of consciousness may be further
defined by testing cognition or comprehension (as with
RASS and ATICE), or sustainability (as with RASS). These
instruments (RSS, RASS, ATICE, and MSAT) rely upon
noting a simple response (movement, eye opening, or
following a command such as ‘look at me’) spontaneously or
responses to simple cues (speaking to the patient or
physically stimulating the patient) that proceed in a logical
progression reflecting progressively deeper sedation [42].
This structure produces little overlap in levels of consciousness because of the step-wise approach, but the assessment
can be quickly performed and the results easily recalled. In
contrast, the structure of some instruments is to sum multiple
subscales [38,40] or to test multiple criteria for each sedation
level [36,37], thus adding complexity and potentially impairing
ease of recall.
Assessment of agitation
Assessment of agitation, or conversely of calmness, is
another important domain that is measured using many
sedation instruments, either as a distinct subscale (VICS and
ATICE) or incorporated into a single scale (SAS, MAAS, and
RASS). With RASS various levels of agitation are assigned
positive numbers, whereas sedation levels receive negative
numbers, providing distinction despite the single scale
design. Research suggests that the majority of ICU patients
exhibit agitation at some time during their ICU stay [51]. This
is an important patient safety concern because behaviors
such as aggressive behavior against care givers or selfremoval of an important tube or catheter can have serious
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consequences [52-55]. Use of a sedation-agitation scale can
enhance identification of agitation or anxiety, thus prompting
therapeutic intervention [1] and reducing the subsequent
incidence of agitation [31], as well as leading to
identification and better management of pain, delirium, or
other conditions that might produce agitation [2,51,54,
56,57]. It is worth emphasizing that agitated behavior may
be a manifestation of inadequate pain control or it could be
due to distress from a problem that requires immediate
attention, such as a malpositioned endotracheal tube or
myocardial ischemia.
Testing of validity and reliability
ICU sedation instruments that have been tested for inter-rater
reliability and validity in multiple patient populations are
summarized in Table 3, listed in order of year of publication.
Inter-rater reliability has been formally tested in research
investigators, as well as in clinical ICU nurses, for most of
these instruments, as noted in Table 3 [36-41,58-60]. It is
noteworthy that some scales such as SAS and RASS have
been tested extensively, including as many as five raters
representing nurses, physicians, and pharmacists, in research
and clinical settings, at multiple hospitals, and in different
patient populations (with or without mechanical ventilation).
Excellent reliability has been demonstrated for the majority of
scales. Face, construct, or criterion validity has been demonstrated for many of the domains of these instruments using a
variety of comparators. These comparators include expert
opinion [40,41,59], quantity of sedative drug administered
[40,41,58], visual-analog scales [39,59,61], other sedation
instruments [36,39,41,58,62], processed electroencephalography (EEG) such as Bispectral Index (BIS) and Patient
State Index (PSI) [61,63-69], and limb acceleration and
movement using actigraphy [62] or digital imaging [70]
(Table 3). In most cases good to excellent validity is demonstrated. Far less work has been conducted to validate the
agitation domain of sedation-agitation scales. Additionally,
some scales incorporate domains that are more difficult to
validate. For example, the motor activity domain of the MSAT
exhibited only weak correlations with the comparator (the
VICS calmness scale).
Impact of the use of sedation scales
Implementation of a sedation assessment instrument can
have a positive impact on precision of sedative administration
[71,72], with greater frequency of appropriate sedation level
and lower incidence of over-sedation, reduction in sedative
and analgesic drug doses, shorter duration of mechanical
ventilation, and even reduced use of vasopressor medications. Implementation of strategies that incorporate scheduled
assessment for agitation, within the context of additional
monitoring and targeted management, has been associated
with a reduction in agitation, shorter duration of mechanical
ventilation, and even fewer nosocomial infections [31,57].
Use of a sedation scale is an integral component of most
patient-focused management algorithms.

The regular performance and documentation of level of
sedation and agitation using a logical, easy to use, validated
instrument is strongly recommended because it promotes
optimal patient-focused sedation management. The authors
endorse RSS and RASS (Tables 4 and 5, respectively) as
sedation scales, which have excellent inter-rater reliability and
validity, and were the most frequently used sedation scales in
the latest survey [18].

Objective measurement of cerebral function
in the intensive care unit setting
The intense management of the conscious state and mental
well being are as important as critical care for any other major
organ system. The brain is the most important organ in the
human body, but it is not closely monitored routinely in most
ICUs. Sedation scoring systems have been well validated for
the management of sedation in the critical care environment,
with improved outcomes when they are used effectively.
Cerebral function monitors offer a more objective method of
monitoring both sedation level and mental well being in the
ICU. The electrical activity recorded from the cortex of the
brain may be affected by cerebral perfusion, cerebral
metabolism, hypoxia, sedative pharmacologic agents, and
seizure activity. Cerebral insults may be detected early while
they are still reversible, so that therapeutic measures may be
taken. Therefore, as part of the patient safety culture now
being developed in the health care system, cerebral function
monitoring may be a vital tool in pursuing this objective.
Cerebral function monitors
The available cortical activity monitors record the cortical
EEG signals and use the frequency, power, or disorder of
these signals to determine the patient’s status. These
monitors process data through various proprietary algorithms
to a dimensionless number that reflects the depth of sedation
of the brain. The effect of sedative drugs on the electrical
activity of the human brain was first reported in 1937 [73].
The very sensitive 20-channel devices were not conducive to
routine clinical monitoring, so in 1969 a simpler two-channel
device was developed that recorded cortical activity as a
continuous power strip. The width of the power band was
dependent on the amount and frequency of the cortical
electrical signal [74]. Since then many different
methodologies have been developed to process and simplify
the EEG signal. The overall goal was to quantify the EEG
signal in a display that can be easily interpreted by the
practitioner. The Cooley and Tukey algorithm applied to the
Fourier theorem - the Fast Fourier Transform - allows a power
versus frequency histogram to be developed that may be
displayed as a spectral array. This concept has led to
application of these monitors as tools for the objective
measurement of the depth of sedation. However, this
approach relies on the concept that consciousness lies at a
cortical level, which perhaps is an over-simplification of a very
complex process. Cortical electrical activity may only be an
expression of consciousness.
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Table 4
Ramsay Sedation Scale
Score

Definition

1

Anxious and agitated or restless or both

2

Cooperative, oriented, and tranquil

3

Responds to commands only

4

Brisk response to a light glabellar tap or loud auditory
stimulus

5

Sluggish response to a light glabellar tap or loud
auditory stimulus

6

No response to a light glabellar tap or loud auditory
stimulus

Performed using a series of steps: observation of behavior (score 1 or
2), followed (if necessary) by assessment of response to voice (score
3), followed (if necessary) by assessment of response to loud auditory
stimulus or light glabellar tap (score 4 to 6) [35].
Table 5

index. The BIS algorithm has been compared with a growing
database of clinical data and continues to be updated. The
resulting BIS number has been correlated with a minimal
value that should be attained to prevent patient awareness
under anesthesia or sedation [75]. The BIS displays a raw
EEG trace obtained from a two-channel sensor but only from
a unilateral prefrontal lobe site, and a power trend is
displayed with a number from 0 to 100 (0 indicating no
cortical activity and 100 a patient who is wide awake). There
are no units of measurement and one patient’s response to a
sedation agent may be dependent on many factors, so
whether a BIS number can correlate uniformly with depth of
sedation remains controversial. The effect of the
electromyogram (EMG) signal may artificially increase the BIS
number. This can be detected by viewing the raw signal and
seeing the high frequency of the EMG signal within the low
voltage signal from EEG. Filters designed to remove the EMG
signal have limited efficiency with any of the cortical monitors.
However, the EMG signal may be used as a guide to the
elimination of muscle relaxant drugs and the return of muscle
activity - another type of twitch monitor.

Richmond Agitation-Sedation Scale
Score

Term

Description

+4

Combative

Overtly combative or violent,
immediate danger to staff

+3

Very agitated

Pulls on or removes tube(s) or
catheter(s) or exhibits aggressive
behavior toward staff

+2

Agitated

Frequent nonpurposeful movement or
patient-ventilator dys-synchrony

+1

Restless

Anxious or apprehensive but
movements not aggressive or
vigorous

0

Alert and calm

-1

Drowsy

Not fully alert, but has sustained
(>10 seconds) awakening, with eye
contact, to voice

-2

Light sedation

Briefly (<10 seconds) awakens with
eye contact to voice

-3

Moderate sedation

Any movement (but no eye contact)
to voice

-4

Deep sedation

No response to voice, but any
movement to physical stimulation

-5

Unarousable

No response to voice or physical
stimulation

Performed using a series of steps: observation of behaviors (score +4
to 0), followed (if necessary) by assessment of response to voice
(score -1 to -3), followed (if necessary) by assessment of response to
physical stimulation such as shaking shoulder and then rubbing
sternum if no response to shaking shoulder (score -4 to -5) [39].

The BIS (Aspect Medical Systems, Norwood, MA, USA) is
composed of time domain, frequency domain, and high-order
spectral subparameters. This integrates several disparate
descriptors using a proprietary algorithm into a dimensionless
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(page number not for citation purposes)

The PSI, displayed on the Sedline Monitor (Hospira, Lake
Forest, IL, USA), is another approach to quantifying cerebral
cortical activity. This monitor has four channels and monitors
both hemispheres of the brain. Similar to the BIS, the PSI
converts the raw EEG signal using the Fast Fourier Theorem
and a proprietary algorithm to display a dimensionless scale
from 0 to 100 that reflects the depth of sedation of the
patient. The scale is updated every 1.2 seconds, which
makes this monitor quick to respond to changes in cerebral
cortical activity. The PSI algorithm was constructed following
an analysis of the quantitative EEG changes that accompanied the loss and return of consciousness after
administration of sedative drugs. It was validated in a large
database of patients and volunteers [76].
The Cerebral State Monitor (Danmeter A/S, Odense,
Denmark) is a handheld wireless device that also uses a
proprietary algorithm and a 0 to 100 scale, with 40 to 60
indicating an adequate depth of hypnosis. The Cerebral State
Index (CSI) that is calculated by the device is derived from
the time and frequency domain analysis, which inputs into a
fuzzy logic inference system that calculates the index. In a
comparative study, both the BIS and the CSI had a predictive
probability statistic for depth of anesthesia of 0.87, which
demonstrates good performance [77]. The CSI performed
better for deeper levels of anesthesia than the BIS, which
was better at lighter levels.
The Narcotrend monitor (MonitorTechnik, Bad Bramstedt,
Germany) is another monitor that processes raw EEG signals
using one-channel or two-channel recordings from different
electrode positions. Early models graded the depth of
hypnosis into five stages from A (awake) to F (very deep level
of anesthesia). The latest Narcotrend software (version 4.0)

Available online http://ccforum.com/content/12/S3/S2

Figure 1

The jagged blue line represents display of Patient State Index (PSI) and suppression ratio (SR) is shown by the red line falling below 0, over time.
Solid triangles represent stimulation of patient and stars represent onset and offset of ventricular tachycardia (VT). Ventricular tachycardia with
hypotension resulted in a precipitous fall in PSI and SR, with recovery following termination of VT. Reproduced with permission from Ramsay M:
Role of brain function monitoring in the critical care and perioperative settings. Semin Anesth Periop Med Pain 2005, 24:195-202. [89].

now calculates the Narcotrend Index, another dimensionless
0 to 100 scale that is similar to those calculated by the
monitors described above. When compared with BIS, the
performance of the Narcotrend Index in terms of prediction
probability of depth of sedation was slightly better than BIS
(predictive probability statistic 0.88, as compared with
0.85) [78].
Additional approaches to brain monitoring
Additional approaches to brain monitoring in the ICU include
response entropy and state entropy [79]. The irregularity of
the EEG signal can be quantified, and by using an algorithm
that is in the public domain, quantified to reflect depth of
sedation. This Entropy Monitor (GE Healthcare, Fairfield, CT,
USA) utilizes the EMG signal, which may provide information
useful for assessing whether a patient is responding to an
external stimulus, for instance a painful stimulus. The
combination of EEG and EMG is presented as the response
entropy, and the lower frequency EEG signals alone are
presented as the state entropy. The prediction probability

values of the entropy indices for differentiating between
consciousness and unconsciousness are high and
comparable with those for BIS [80]. Noxious stimulation does
increase the difference between response entropy and state
entropy, but an increase in the difference does not always
indicate inadequate analgesia [81].
Auditory evoked responses have extensively been studied
with increasing depths of sedation [82]. Auditory stimuli
stimulate the auditory axis, and the middle-latency auditory
evoked responses are reduced in amplitude and elevated in
terms of latency with increases in sedation. This Auditory
Evoked Potential monitor (Danmeter A/S) studies more than
just cortical electrical activity. The monitor uses an algorithm
that calculates a numerical index, the Alaris Auditory
Response Index (AAI™), from the latency and amplitude of the
evoked potential. AAI™ transforms the AEP (auditory evoked
potential) and the EEG signal into a value on a 0 to 100 scale
that is used to measure depth of sedation. This index
correlates well with the BIS index [83].
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Figure 2

The jagged blue line represents display of Patient State Index (PSI) and suppression ratio (SR) is shown by the red line falling below 0, over time.
Solid triangles represent stimulation of patient. Accidental mis-programming of propofol infusion rate resulted in a steady decline in PSI and SR
over time. Recognition of mis-programmed rate was recognized and corrected, resulting in return of PSI and SR to baseline values. Reproduced
with permission from Ramsay M: Role of brain function monitoring in the critical care and perioperative settings. Semin Anesth Periop Med Pain
2005, 24:195-202. [89].

The current role of objective cerebral function
monitoring in the intensive care unit
The use of these cerebral function monitors as objective
monitors of depth of sedation in the ICU has not yet been
universally embraced. This is because many factors may alter
the signal in the critically ill patient, particularly EMG signals,
which can cause erroneously high BIS and PSI scores. These
artifacts can be identified by observing the raw EEG signal
and seeing a very high frequency low voltage ‘noise’ within
the EEG signal. Thus, an understanding of the basic EEG
signal is important to interpreting the data presented by these
cerebral function monitors. A variety of confounders,
including EMG interference, sleep, drugs such as
catecholamines, and temperature changes, may influence the
BIS value [84]. In a comprehensive review, LeBlanc and
colleagues [84] demonstrated mixed results when BIS was
correlated with clinical sedation scales, with r2 ranging from
0.21 to 0.93. Much of the variability is probably related to
EMG interference, because BIS values decline significantly
Page 10 of 13
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when muscle relaxants are administered to ICU patients
[85,86].
Where does cerebral function monitoring fit into current ICU
practice? The recommendations found in SCCM’s Clinical
Practice Guidelines, published in 2002, do not endorse
routine use [1]. They state that ‘objective measures of sedation such as BIS have not yet been evaluated and are not yet
proven in the ICU’, based upon grade C evidence. Although
there is evidence for better operating room outcomes, such
as early recognition of unintended awareness [75] or better
anesthetic management [87], such evidence is scant in the
ICU setting. The incidence of unintended awareness in the
ICU is unknown and is mainly observed in those patients who
are paralyzed either as a result of their disease process or the
use of muscle relaxants. This patient group may be well
served by monitoring, because the sequelae of inadequate
sedation are severe. Accordingly, use of cerebral function
monitoring is likely to be of greatest benefit in patients who

Available online http://ccforum.com/content/12/S3/S2

are deeply sedated or who are receiving muscle relaxant
medications [1,88]. The most compelling reason to promote
further research and clinical experience in cerebral function
monitoring in the ICU is patient safety. Examples of changes
in PSI in response to clinical events are noted in Figures 1
and 2 [89]. Cerebral insults may be detected at a stage when
they are still reversible. The brain is the most complex and
most important organ in the human body and deserves more
attention than it currently receives. Cerebral function monitors
may provide another level of safety for our patients and, as
this area of technology advances, improved care of the
mental and cognitive functions of the critical care patient is
likely to follow.
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10.

Conclusion
Evaluation and monitoring of pain, agitation, and level of
consciousness can be accomplished by subjective scales
that can contribute to enhanced communication among care
givers and to more effective analgesia and sedation management. These relatively simple tools can be repeatedly applied,
promoting close monitoring of changing circumstances and
response to therapy. Some instruments add other measures
of patient tolerance of the ICU environment, such as patientventilator synchrony. More work is needed to promote more
widespread use of these tools and to address barriers to
implementation. Furthermore, strategies that examine multiple
aspects of patient distress and comfort, including tolerance
to the ICU and interventions, are increasingly important.
Future directions also include advancing the technology of
objective monitoring of cerebral function in order to allow
better adaptation to the ICU setting (as compared with the
operating theater) and demonstrating benefits in meaningful
outcomes as a result of continuous, objective monitoring.
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